Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Masson

Showing results (291-300 of 301) with videos related to

Pageof 31
Sort By:
Cell Host & Microbe|June 5, 2024
Epithelial hypoxia maintains colonization resistance against Candida albicansHannah P Savage, Derek J Bays, Connor R Tiffany, et al.
The Journal of Antimicrobial Chemotherapy|February 18, 2015
Synergy of chemotherapy and immunotherapy revealed by a genome-scale analysis of murine tuberculosisRodrigo F Rodrigues, Carlos R Zárate-Bladés, Wendy M Rios, et al.
The International Journal of Risk & Safety in Medicine|December 8, 2015
6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's diseaseI V Zueva, V E Semenov, M A Mukhamedyarov, et al.
Acta Naturae|January 23, 2016
Chemical Polysialylation and In Vivo Tetramerization Improve Pharmacokinetic Characteristics of Recombinant Human Butyrylcholinesterase-Based BioscavengersS S Terekhov, I V Smirnov, O G Shamborant, et al.
Human Vaccines & Immunotherapeutics|March 11, 2014
Immunotherapy of tuberculosis with Mycobacterium leprae Hsp65 as a DNA vaccine triggers cross-reactive antibodies against mammalian Hsp60 but not pathological autoimmunityNayara T S Doimo, Carlos R Zárate-Bladés, Rodrigo F Rodrigues, et al.
BMC Immunology|July 24, 2008
Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomesRogério S Rosada, Lucimara Gaziola de la Torre, Fabiani G Frantz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2023
Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1B Besse, E Felip, R Garcia Campelo, et al.
Cell Host & Microbe|August 24, 2024
Salmonella re-engineers the intestinal environment to break colonization resistance in the presence of a compositionally intact microbiotaAndrew W L Rogers, Lauren C Radlinski, Henry Nguyen, et al.
Expert Opinion on Biological Therapy|August 13, 2008
Protective efficacy of different strategies employing Mycobacterium leprae heat-shock protein 65 against tuberculosisPatrícia R M Souza, Carlos R Zárate-Bladés, Juliana I Hori, et al.
Antiviral Research|July 14, 2024
A mimetic peptide of ACE2 protects against SARS-CoV-2 infection and decreases pulmonary inflammation related to COVID-19Ernna H Oliveira, Ana C Monteleone-Cassiano, Lucas Tavares, et al.
Pageof 31

Showing results (291-300 of 301) with videos related to

Sort By:
Pageof 31
Cell Host & Microbe|June 5, 2024
Epithelial hypoxia maintains colonization resistance against Candida albicansHannah P Savage, Derek J Bays, Connor R Tiffany, et al.
The Journal of Antimicrobial Chemotherapy|February 18, 2015
Synergy of chemotherapy and immunotherapy revealed by a genome-scale analysis of murine tuberculosisRodrigo F Rodrigues, Carlos R Zárate-Bladés, Wendy M Rios, et al.
The International Journal of Risk & Safety in Medicine|December 8, 2015
6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's diseaseI V Zueva, V E Semenov, M A Mukhamedyarov, et al.
Acta Naturae|January 23, 2016
Chemical Polysialylation and In Vivo Tetramerization Improve Pharmacokinetic Characteristics of Recombinant Human Butyrylcholinesterase-Based BioscavengersS S Terekhov, I V Smirnov, O G Shamborant, et al.
Human Vaccines & Immunotherapeutics|March 11, 2014
Immunotherapy of tuberculosis with Mycobacterium leprae Hsp65 as a DNA vaccine triggers cross-reactive antibodies against mammalian Hsp60 but not pathological autoimmunityNayara T S Doimo, Carlos R Zárate-Bladés, Rodrigo F Rodrigues, et al.
BMC Immunology|July 24, 2008
Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomesRogério S Rosada, Lucimara Gaziola de la Torre, Fabiani G Frantz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2023
Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1B Besse, E Felip, R Garcia Campelo, et al.
Cell Host & Microbe|August 24, 2024
Salmonella re-engineers the intestinal environment to break colonization resistance in the presence of a compositionally intact microbiotaAndrew W L Rogers, Lauren C Radlinski, Henry Nguyen, et al.
Expert Opinion on Biological Therapy|August 13, 2008
Protective efficacy of different strategies employing Mycobacterium leprae heat-shock protein 65 against tuberculosisPatrícia R M Souza, Carlos R Zárate-Bladés, Juliana I Hori, et al.
Antiviral Research|July 14, 2024
A mimetic peptide of ACE2 protects against SARS-CoV-2 infection and decreases pulmonary inflammation related to COVID-19Ernna H Oliveira, Ana C Monteleone-Cassiano, Lucas Tavares, et al.
Pageof 31